Midway Specialty Care Center · Temple Terrace, FL
Hepatitis Treatment in Temple Terrace, Florida
Board-certified infectious disease specialists providing expert hepatitis B and C diagnosis, treatment, and long-term liver health monitoring.
Hepatitis Care in Temple Terrace
Modern Hepatitis Treatment
Hepatitis B and C are serious liver infections caused by viruses that can be transmitted through blood, sexual contact, or from mother to child. Left untreated, both can lead to chronic liver disease, cirrhosis, or liver cancer — but with the right care, outcomes have dramatically improved. Hepatitis C is now curable in the vast majority of patients, and hepatitis B can be effectively managed long-term.
At Midway Specialty Care Center in Temple Terrace, our infectious disease physicians specialize in the diagnosis and treatment of viral hepatitis. We provide individualized care plans, access to the latest FDA-approved therapies, and the ongoing liver monitoring needed to protect your health over the long term.
Whether you were recently diagnosed, referred by another physician, or have been living with hepatitis for years without treatment, we're ready to help.
What Hepatitis Care at Midway Includes
Comprehensive evaluation, treatment, and monitoring.
Hepatitis C Treatment (Curative)
Modern direct-acting antiviral (DAA) therapy can cure hepatitis C in more than 95% of patients — often with just 8–12 weeks of once-daily oral medication. We determine the best DAA regimen based on your viral genotype, liver fibrosis stage, and prior treatment history, and provide close monitoring throughout to confirm cure.
Hepatitis B Management & Treatment
Unlike hepatitis C, chronic hepatitis B currently has no cure, but it can be effectively managed with antiviral therapy to suppress viral replication, protect liver function, and reduce the risk of cirrhosis and liver cancer. We evaluate whether treatment is indicated based on viral load, liver enzymes, and fibrosis stage, and provide long-term follow-up care.
Liver Function & Viral Load Monitoring
Regular laboratory testing is central to hepatitis management. We monitor liver enzyme levels (ALT/AST), viral load, hepatitis antigen and antibody markers, and bilirubin — tracking how your liver is responding to treatment and whether the virus is being suppressed or eliminated. Monitoring frequency is tailored to your specific situation.
Medication Access Through 340B
Direct-acting antiviral medications for hepatitis C can cost tens of thousands of dollars without assistance. As a federally qualified 340B nonprofit clinic, we can provide these medications at dramatically reduced costs for eligible patients. Our team also assists with insurance prior authorizations and pharmaceutical patient assistance programs.
HIV / Hepatitis Co-Infection Management
HIV and hepatitis C frequently occur together, and HIV infection can accelerate liver disease progression in patients with hepatitis. Our infectious disease physicians are experienced in managing co-infected patients — coordinating HIV antiretroviral therapy alongside hepatitis treatment for optimal outcomes in both conditions.
Your Care Team in Temple Terrace
Board-certified specialists with expertise in hepatitis B and C treatment.
Dr. Moti Ramgopal
MD, FACP, FIDSA, Chairman
Dr. Moti Ramgopal is the Founder and Director of Midway Immunology and Research Center and the Founder/Chairman of the not-for-profit Midway Specialty Care Center in Florida and Guyana. Additionally, he is a Consultant Physician/Director of Associates in Infectious Diseases and a Clinical Professor at Florida State University College of Medicine. He also serves as an HIV Consultant for the Ministry of Health in the Turks and Caicos Islands. Dr. Ramgopal is certified by the American Board of Internal Medicine and Infectious Diseases with expertise in clinical research and the rapid implementation of novel, cutting-edge treatments for over 25 years. As Principal Investigator at Midway Immunology and Research Center, he has overseen 300+ clinical trials, with his research published in peer-reviewed journals and presented at various national and international conferences. His work has been published in the Lancet, Journal of Clinical Infectious Diseases, and Journal of Acquired Immune Deficiency Syndromes. Additionally, he has presented research at the 2023 International AIDS Society Conference on HIV Science and the Conference on Retroviruses and Opportunistic Infections. As a Consulting Physician, he is affiliated with multiple hospitals within the Treasure Coast area. His team provides comprehensive services such as wound care and outpatient IV antibiotics (OPAT). In addition, he provides opportunities for patients to transfer from inpatient care to outpatient medicine through the availability of an infusion center. Through Midway Specialty Care Center, Dr. Ramgopal and his team embrace the initiative of ending the HIV and HCV epidemics by 2030 in critical communities throughout Florida. To expand the organization's reach, he established two clinics in Georgetown, Guyana, providing the community with new opportunities and access to various clinical and laboratory services. Due to his experiences and efforts, US News and World Reports recognized Dr. Ramgopal as a top Infectious Disease Doctor. Dr. Ramgopal received his medical degree from the University of the West Indies Faculty of Medical Sciences and completed a Residency in Internal Medicine at Beaumont Hospital in Michigan. He then completed a Fellowship in Infectious Diseases at Jackson Memorial and the University of Miami School of Medicine. Dr. Ramgopal is passionate about integrating healthcare from developed to underdeveloped communities, especially in the Caribbean, by introducing advancing technologies, clinical research, and trials. Originally from Guyana and previously the Medical Director of PEPFAR in Guyana, he opened a clinic in Georgetown, Guyana, in 2019 where he actively gives back to the community he grew up in. In addition, Dr. Ramgopal continues to explore opportunities to reach high-risk groups nationally and internationally by providing opportunities to practice medicine, educational training, and consultation services.
Dr. Moti Ramgopal
MD, FACP, FIDSA, Chairman
Dr. Moti Ramgopal is the Founder and Director of Midway Immunology and Research Center and the Founder/Chairman of the not-for-profit Midway Specialty Care Center in Florida and Guyana. Additionally, he is a Consultant Physician/Director of Associates in Infectious Diseases and a Clinical Professor at Florida State University College of Medicine. He also serves as an HIV Consultant for the Ministry of Health in the Turks and Caicos Islands. Dr. Ramgopal is certified by the American Board of Internal Medicine and Infectious Diseases with expertise in clinical research and the rapid implementation of novel, cutting-edge treatments for over 25 years. As Principal Investigator at Midway Immunology and Research Center, he has overseen 300+ clinical trials, with his research published in peer-reviewed journals and presented at various national and international conferences. His work has been published in the Lancet, Journal of Clinical Infectious Diseases, and Journal of Acquired Immune Deficiency Syndromes. Additionally, he has presented research at the 2023 International AIDS Society Conference on HIV Science and the Conference on Retroviruses and Opportunistic Infections. As a Consulting Physician, he is affiliated with multiple hospitals within the Treasure Coast area. His team provides comprehensive services such as wound care and outpatient IV antibiotics (OPAT). In addition, he provides opportunities for patients to transfer from inpatient care to outpatient medicine through the availability of an infusion center. Through Midway Specialty Care Center, Dr. Ramgopal and his team embrace the initiative of ending the HIV and HCV epidemics by 2030 in critical communities throughout Florida. To expand the organization's reach, he established two clinics in Georgetown, Guyana, providing the community with new opportunities and access to various clinical and laboratory services. Due to his experiences and efforts, US News and World Reports recognized Dr. Ramgopal as a top Infectious Disease Doctor. Dr. Ramgopal received his medical degree from the University of the West Indies Faculty of Medical Sciences and completed a Residency in Internal Medicine at Beaumont Hospital in Michigan. He then completed a Fellowship in Infectious Diseases at Jackson Memorial and the University of Miami School of Medicine. Dr. Ramgopal is passionate about integrating healthcare from developed to underdeveloped communities, especially in the Caribbean, by introducing advancing technologies, clinical research, and trials. Originally from Guyana and previously the Medical Director of PEPFAR in Guyana, he opened a clinic in Georgetown, Guyana, in 2019 where he actively gives back to the community he grew up in. In addition, Dr. Ramgopal continues to explore opportunities to reach high-risk groups nationally and internationally by providing opportunities to practice medicine, educational training, and consultation services.
View Full Profile →
Rodrigo Sabec
APRN
Rodrigo Sabec is originally from Brazil but relocated and settled in the Tampa area. He received his Master's degree in Sciences of Nursing from South University in Tampa, Florida, and he is Board Certified by The American Academy of Nurse Practitioners National Certification Board, Inc. as a Family Nurse Practitioner. He has a focused interest in HIV treatment, transgender care and PrEP and enjoys spending time with Ginger and Ella (his dogs) and loved ones.
Rodrigo Sabec
APRN
Rodrigo Sabec is originally from Brazil but relocated and settled in the Tampa area. He received his Master's degree in Sciences of Nursing from South University in Tampa, Florida, and he is Board Certified by The American Academy of Nurse Practitioners National Certification Board, Inc. as a Family Nurse Practitioner. He has a focused interest in HIV treatment, transgender care and PrEP and enjoys spending time with Ginger and Ella (his dogs) and loved ones.
View Full Profile →
Who We Help
Our clinic treats patients at every stage of disease.
Newly Diagnosed
If you've recently tested positive for hepatitis B or C, we'll walk you through what your diagnosis means, what testing is needed to understand your liver health, and what treatment options are available — clearly and without alarm.
Living With Untreated Hepatitis
Many people live with hepatitis B or C for years without treatment — either because they weren't aware of treatment options or faced barriers to access. It's not too late to start. Modern therapies are far more effective and tolerable than older regimens.
HIV / Hepatitis Co-Infection
Patients living with HIV who also have hepatitis B or C require specialized care that addresses both infections simultaneously. Our infectious disease team manages co-infected patients with the depth of expertise both conditions demand.
Transferring Care
Moving your hepatitis care to a new provider is straightforward. We'll review your prior records, continue or adjust your current management plan, and provide coordinated follow-up — including any needed imaging or referrals.
What to Expect at Your First Visit
Getting the right evaluation is the first step toward effective treatment.
Schedule Your Appointment
Call our Temple Terrace office at (813) 733-8224 or submit the request form. If you have prior lab results or records from another provider, bring them along — they help us understand where you are in your diagnosis and avoid duplicating tests already completed.
Diagnostic Evaluation & Lab Work
Your provider will review your health history and order any needed lab work — including viral load, genotype testing for hepatitis C, liver enzyme panels, and hepatitis antigen/antibody markers. For patients with known disease, we assess the degree of liver fibrosis to guide treatment decisions.
Treatment Plan & Medication Start
Once results are reviewed, your provider will discuss your treatment options in plain language. For hepatitis C, we'll select the right DAA regimen and handle any insurance prior authorization. For hepatitis B, we'll determine whether antiviral therapy is indicated now or whether monitoring is the appropriate first step.
Ongoing Monitoring & Follow-up
For hepatitis C patients on DAA therapy, follow-up labs are scheduled during and after treatment to confirm the virus is clearing. Cure is confirmed with a sustained virologic response (SVR) 12 weeks after completing treatment. Hepatitis B patients receive regular liver function monitoring on a schedule based on viral activity and treatment status.
Book an Appointment
Temple Terrace · Hepatitis B & C
Use our secure online scheduler to choose a convenient date and time for your hepatitis consultation.
Book Appointment OnlineOr call (813) 733-8224
Contact Us
11454 North 53rd St
Temple Terrace, FL 33617
Clinic Fax
(813) 733-8228
Hours of Operation
New Patient Paperwork
After your appointment is confirmed, you'll receive a link to complete your intake forms online before your visit — from any device, no printing required.
Prefer Paper?
Download and print the forms below if you'd like to complete them by hand before your visit.
Patient Reviews
“The doctor spent an enormous amount of time going over my records and truly explaining to us what was happening, unlike any other doctor.”
— Matt M.